HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- methyl- 1- (2- methyl- 5- nitrophenylsulfonyl)- 1H- benzo(d)imidazole

inhibits the insulin promoter; structure in first source

Also Known As:

BI6015

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 2-methyl-1-(2-methyl-5-nitrophenylsulfonyl)-1H-benzo(d)imidazole: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - 2-methyl-1-(2-methyl-5-nitrophenylsulfonyl)-1H-benzo(d)imidazole: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - 2-methyl-1-(2-methyl-5-nitrophenylsulfonyl)-1H-benzo(d)imidazole: 1

Experts

1.	Bucher, Simon: 1 article (12/2015)
2.	Denizot, Claire: 1 article (12/2015)
3.	Fardel, Olivier: 1 article (12/2015)
4.	Jouan, Elodie: 1 article (12/2015)
5.	Le Vee, Marc: 1 article (12/2015)
6.	Mayati, Abdullah: 1 article (12/2015)
7.	Moreau, Amélie: 1 article (12/2015)
8.	Parmentier, Yannick: 1 article (12/2015)
9.	Stieger, Bruno: 1 article (12/2015)

Related Diseases

1.	Neoplasms (Cancer) 12/15/2015 - "PMA was finally shown to cause epithelial-mesenchymal transition (EMT) in HepaRG cells and exposure to various additional EMT inducers, i.e., hepatocyte growth factor, tumor growth factor-β1 or the HNF4α inhibitor BI6015, led to transporter expression alterations highly correlated to those triggered by PMA. "

Related Drugs and Biologics

1.	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)